Literature DB >> 21898477

Intensive care of the patient with cirrhosis.

Jody C Olson1, Julia A Wendon, David J Kramer, Vicente Arroyo, Rajiv Jalan, Guadalupe Garcia-Tsao, Patrick S Kamath.   

Abstract

Acute deterioration of patients with cirrhosis manifests as multiple organ failure requiring admission to an intensive care unit. Precipitating events may be viral hepatitis, typically in Asia, and drug or alcoholic hepatitis and variceal hemorrhage in the West. Patients with cirrhosis in the intensive care unit have a high mortality, and each admission is associated with a mean charge of US $116,200. Prognosis is determined by the number of organs failing (sequential organ failure assessment [SOFA] score), the presence of infection, and the degree of liver dysfunction (Child-Turcotte-Pugh or Model for End-Stage Liver Disease scores). The most common organ failing is the kidney; sepsis is associated with further deterioration in liver function by compromise of the microcirculation. Care of these critically ill patients with impending multiple organ failure requires a team approach with expertise in both hepatology and critical care. Treatment is aimed at preventing further deterioration in liver function, reversing precipitating factors, and supporting failing organs. Liver transplantation is required in selected patients to improve survival and quality of life. Treatment is futile in some patients, but it is difficult to identify these patients a priori. Artificial and bioartificial liver support systems have thus far not demonstrated significant survival benefit in these patients.
Copyright © 2011 American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Year:  2011        PMID: 21898477     DOI: 10.1002/hep.24622

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  61 in total

Review 1.  Bacterial infections in end-stage liver disease: current challenges and future directions.

Authors:  Jasmohan S Bajaj; Jacqueline G O'Leary; Florence Wong; K Rajender Reddy; Patrick S Kamath
Journal:  Gut       Date:  2012-06-03       Impact factor: 23.059

Review 2.  Acute-on-Chronic Liver Failure.

Authors:  Sumeet K Asrani; Douglas A Simonetto; Patrick S Kamath
Journal:  Clin Gastroenterol Hepatol       Date:  2015-07-15       Impact factor: 11.382

3.  Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL) 2014.

Authors:  Shiv Kumar Sarin; Chandan Kumar Kedarisetty; Zaigham Abbas; Deepak Amarapurkar; Chhagan Bihari; Albert C Chan; Yogesh Kumar Chawla; A Kadir Dokmeci; Hitendra Garg; Hasmik Ghazinyan; Saeed Hamid; Dong Joon Kim; Piyawat Komolmit; Suman Lata; Guan Huei Lee; Laurentius A Lesmana; Mamun Mahtab; Rakhi Maiwall; Richard Moreau; Qin Ning; Viniyendra Pamecha; Diana Alcantara Payawal; Archana Rastogi; Salimur Rahman; Mohamed Rela; Anoop Saraya; Didier Samuel; Vivek Saraswat; Samir Shah; Gamal Shiha; Brajesh Chander Sharma; Manoj Kumar Sharma; Kapil Sharma; Amna Subhan Butt; Soek Siam Tan; Chitranshu Vashishtha; Zeeshan Ahmed Wani; Man-Fung Yuen; Osamu Yokosuka
Journal:  Hepatol Int       Date:  2014-09-26       Impact factor: 6.047

4.  Organ dysfunctions in patients with alcoholic cirrhosis.

Authors:  Richard Moreau
Journal:  Hepatol Int       Date:  2014-04-03       Impact factor: 6.047

5.  Second infections independently increase mortality in hospitalized patients with cirrhosis: the North American consortium for the study of end-stage liver disease (NACSELD) experience.

Authors:  Jasmohan S Bajaj; Jacqueline G O'Leary; K Rajender Reddy; Florence Wong; Jody C Olson; Ram M Subramanian; Geri Brown; Nicole A Noble; Leroy R Thacker; Patrick S Kamath
Journal:  Hepatology       Date:  2012-12       Impact factor: 17.425

Review 6.  Hepatitis E and Acute-on-Chronic Liver Failure.

Authors:  Ashish Kumar; Vivek A Saraswat
Journal:  J Clin Exp Hepatol       Date:  2013-09-16

7.  The opportunity cost of futile treatment in the ICU*.

Authors:  Thanh N Huynh; Eric C Kleerup; Prince P Raj; Neil S Wenger
Journal:  Crit Care Med       Date:  2014-09       Impact factor: 7.598

8.  Acute-on-Chronic Liver Failure (ACLF) in Coastal Eastern India: "A Single-Center Experience".

Authors:  Girish Kumar Pati; Ayaskanta Singh; Bijay Misra; Debasis Misra; Haribhakti Seba Das; Chittaranjan Panda; Shivaram Prasad Singh
Journal:  J Clin Exp Hepatol       Date:  2015-08-19

Review 9.  Acute-on-chronic liver failure: Pathogenesis, prognostic factors and management.

Authors:  Sara Blasco-Algora; José Masegosa-Ataz; María Luisa Gutiérrez-García; Sonia Alonso-López; Conrado M Fernández-Rodríguez
Journal:  World J Gastroenterol       Date:  2015-11-14       Impact factor: 5.742

10.  Proton pump inhibitors are associated with a high rate of serious infections in veterans with decompensated cirrhosis.

Authors:  J S Bajaj; S M Ratliff; D M Heuman; K L Lapane
Journal:  Aliment Pharmacol Ther       Date:  2012-11       Impact factor: 8.171

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.